Azathioprine/leflunomide/rituximabCOVID-19: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1971卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45177-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：52 / 52

相关论文

共 50 条

[1] Azathioprine/rituximabCOVID-19 reinfection: 2 case reports
Reactions Weekly, 2025, 2053 (1) : 66 - 66
[2] RituximabCOVID-19 infection: 3 case reports
Reactions Weekly, 2021, 1846 (1) : 283 - 283
[3] RituximabCOVID-19: 12 case reports
Reactions Weekly, 2023, 1940 (1) : 369 - 369
[4] RituximabCOVID-19: 2 case reports
Reactions Weekly, 2021, 1843 (1) : 318 - 318
[5] RituximabCOVID-19: 2 case reports
Reactions Weekly, 2022, 1908 (1) : 494 - 494
[6] Methotrexate/prednisone/rituximabCOVID-19 pneumonia: 3 case reports
Reactions Weekly, 2021, 1872 (1) : 307 - 307
[7] RituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 324 - 324
[8] RituximabCOVID-19 infection: 8 case reports
Reactions Weekly, 2021, 1872 (1) : 440 - 440
[9] RituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2020, 1833 (1) : 342 - 342
[10] RituximabCOVID-19 respiratory infection: 9 case reports
Reactions Weekly, 2021, 1863 (1) : 301 - 301

← 1 2 3 4 5 →